ArticleDiseases (Basel, Switzerland)2024

Clinical Outcomes among Hospitalized COVID-19 Patients Who Received Baricitinib or Tocilizumab in Addition to Standard of Care.

Cucnhat P Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.